Growth factors, receptors, and molecular alterations in pancreatic cancer: Putting it all together

Medical Clinics of North America

Volumn 84, Issue 3, 2000, Pages 697-705

  Ulrich II, Charles D ^b  

^a Box 670595   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CANCER GROWTH; CARCINOGENESIS; GENE MUTATION; GENETIC DISORDER; HUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREATITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0034129199     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70252-2     Document Type: Article

References (95)

1. American Cancer Society 1997 Cancer Facts and Figures Atlanta, GA
2. R.J. Aspinall N.R. Lemoine Gene therapy for pancreatic and biliary malignancies Ann Oncol 10 suppl 4 1999 188
3. R. Baldwin H. Friess M. Yokoyama Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibition Int J Cancer 67 1996 283
4. M.D. Barber J.A. Ross A.C. Voss The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer Br J Cancer 81 1999 80
5. S.R. Bramhall J.P. Neoptolemos G.H.W. Stamp Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma J Pathol 182 1997 347
6. R.E. Brand H.T. Lynch Hereditary pancreatic adenocarcinoma: A clinical perspective Med Clin North Am 84 2000
7. T.A. Brentnall Cancer surveillance in patients from hereditary pancreatic cancer kindreds Med Clin North Am 84 2000
8. T.A. Brentnall M.P. Bronner D.R. Byrd Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer Ann Intern Med 131 1999 247
9. C. Caldas S.A. Hahn da Costa L.T. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 1994 27
10. D. Cantero H. Freiss J. Deflorin Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma Br J Cancer 75 1997 388
11. V. Chinswangwatanakul T. Worthington N.R. Lemoine Circulating vascular endothelial growth factor correlates with systemic thrombin generation in patients with pancreatic carcinoma Thromb Haemost 81 1999 851
12. J.A. Cohn K.J. Friedman P.G. Noone Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis N Engl J Med 339 1998 653
13. De Antueno R. M. Bai M. Elliot Tissue distribution and metabolism of gamma-linolenoyl-3-eicosapentaenoyl propane diol enterally or intravenously administered to mice bearing human pancreatic carcinomas Anticancer Res 19 1999 2041
14. Di Renzo M.F. R. Poulsom M. Olivero Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer Cancer Res 55 1995 1129
15. V. Ellenrieder G. Adler T.M. Gress Invasion and metastasis in pancreatic cancer Ann Oncol 10 suppl 4 1999 46
16. T.H. El-Metwally T.E. Adrian Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model Biochem Biophys Res Commun 257 1999 596
17. J.T. Ferrucci Biliopancreatic malignancy current diagnostic possibilities: An overview Ann Oncol 10 suppl 4 1999 143
18. H. Friess Z. Lu H.U. Graber Bax, but not bcl-2, influences the prognosis of human pancreatic cancer Gut 43 1998 414
19. H. Friess Y. Yamanaka M.W. Buchler Enhanced expression of type II TGF β receptor in human pancreatic cancer cells without alterations of type III receptor expression Cancer Res 53 1993 2704
20. H. Friess Y. Yamanaka M.W. Buchler Enhanced expression of transforming growth factor β isoforms in human pancreatic cancer correlates with decreased survival Gastroenterology 105 1993 1846
21. H. Friess Y. Yamanaka M.S. Kobrin Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression Clin Cancer Res 1 1995 1413
22. H. Funatomi J. Itakura T. Ishiwata Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor targeted therapy Int J Cancer 72 1997 512
23. F.M. Giardiello S.B. Welsh S.R. Hamilton Increased risk of cancer in Peutz-Jeghers syndrome N Engl J Med 316 1987 1511
24. M. Goggins M. Schutte J. Lu Germline BRCA2 gene mutations in patients with apparantly sporadic pancreatic carcinomas Cancer Res 56 1996 5360
25. M. Goggins M. Shekher K. Turnacioglu Genetic alterations of the TGF β receptor genes in pancreatic and biliary adenocarcinomas Cancer Res 58 1998 5329
26. A.M. Grau L. Zhang W. Wang Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells Cancer Res 57 1997 3929
27. B. Gudjonsson Carcinoma of the pancreas: Critical analysis of costs, results of resections, and need for standardized reporting J Am Coll Surg 181 1995 483
28. X. Guo H. Friess H.U. Graber KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases Cancer Res 56 1996 4876
29. S. Hahn M. Schutte A.T.M. Hogue DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 1996 350
30. P.A. Hall N.R. Lemoine Models of pancreatic cancer Cancer Surv 16 1993 135
31. E. Hiyama T. Kodama K. Shinbara Telomerase activity is detected in pancreatic cancer but not in benign tumors Cancer Res 57 1997 326
32. L. Huang D. Lang J. Geradts Molecular and immunohistochemical analysis of RB1 and cyclin D1 in human ductal pancreatic adenocarcinomas and cell lines Mol Carcinog 15 1996 85
33. T. Ishiwata U. Bergmann M. Kornmann Altered expression of insulin-like growth factor II receptor in human pancreatic cancer Pancreas 15 1997 367
34. T. Ishiwata H. Friess M.W. Buchler Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer Am J Pathol 153 1998 213
35. J. Itakura T. Ishiwata H. Friess Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression Clin Cancer Res 3 1997 1309
36. J. Itakura T. Ishiwata B. Shen Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer Int J Cancer 85 2000 27
37. S. Jiang E. Kopras M. McMichael Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells Cancer Res 57 1997 1475
38. A. Kaiser H. Herbst G. Fisher Retinoic acid receptor β regulates growth and differentiation in human pancreatic carcinoma cells Gastroenterology 113 1997 920
39. S.E. Kern Molecular genetic alterations in ductal pancreatic adenocarcinoma Med Clin North Am 84 2000
40. J. Kleeff T. Ishiwata A. Kumbasar The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer J Clin Invest 102 1998 1662
41. J. Kleeff T. Ishiwata H. Maruyama The TGF β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer Oncogene 18 1999 5363
42. J. Kleeff H. Maruyama T. Ishiwata Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo Gastroenterology 116 1999 1202
43. E. Kopras J. Cornelius G. Babcock MEK-1 plays an important role in EGF-induction and cAMP-mediated inhibition of ERK phosphorylation and G1 to S phase transition in ductal pancreatic cancer cells Gastroenterology 114 1998 A628
44. M. Korc B. Chandrasekar Y. Yamanaka Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor α J Clin Invest 90 1992 1352
45. M. Kornmann N. Arber M. Korc Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with a loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum J Clin Invest 101 1998 344
46. M. Kornmann H.G. Beger M. Korc Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis Pancreas 17 1998 169
47. A.B. Lowenfels P. Maisonneuve G. Cavallini Pancreatitis and the risk of pancreatic cancer N Engl J Med 328 1997 1433
48. A.B. Lowenfels P. Maisonneuve E.P. DiMagno Hereditary pancreatitis and the risk of pancreatic cancer J Natl Cancer Inst 89 1997 442
49. A.B. Lowenfels P. Maisonneuve D.C. Whitcomb Smoking and the risk of pancreatic cancer in patients with hereditary pancreatitis (HP) Pancreas 19 1999 430
50. Z. Lu H. Friess H.U. Graber Presence of two signaling TGF β receptors in human pancreatic cancer correlates with advanced tumor stage Dig Dis Sci 42 1997 2054
51. H.T. Lynch Genetics and pancreatic cancer Arch Surg 129 1994 266
52. H.T. Lynch L. Fusaro T.C. Smyrk Medical genetic study of eight pancreatic cancer-prone families Cancer Invest 13 1995 141
53. H.T. Lynch T. Smyrk S.E. Kern Familial pancreatic cancer: A review Semin Oncol 23 1996 251
54. H.T. Lynch G. Voorhees S. Lanspa Pancreatic carcinoma and hereditary non-polyposis colorectal cancer: A family study Br J Cancer 52 1985 27
55. S.P. Martin C.D. Ulrich Pancreatic disease in the elderly Clin Geriatr Med 15 1999 579
56. S.P. Martin C.D. Ulrich Pancreatic cancer surveillance in a high risk cohort: Is it worth the cost Med Clin North Am 84 2000
57. H. Maruyama J. Kleeff S. Wildi Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis Am J Pathol 155 1999 815
58. J. Massague TGF β signaling: Receptors, transducers, and Mad proteins Cell 85 1996 947
59. W. Miwa J. Yasuda Y. Murakami Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer Biochem Biophys Res Commun 225 1996 968
60. R. Moonka W. Zhou R.H. Bell Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer J Gastrointest Surg 3 1999 134
61. T. Morohoshi G. Held G. Kloppel Exocrine pancreatic tumors and their histological classification: A study based on 167 autopsy and 97 surgical cases Histopathology 7 1983 645
62. C.A. Moskaluk R.H. Hruban S.E. Kern p16 and K-ras mutations in the intraductal precursors of human pancreatic adenocarcinoma Cancer Res 57 1997 2140
63. M. Naumann N. Savitskaia C. Eilert Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors Gastroenterology 110 1996 1215
64. J.P. Neglia S.C. Fitzsimmons P. Maisonneuve The risk of cancer among patients with cystic fibrosis N Engl J Med 332 1995 494
65. J.E. Niederhuber M.F. Brennan H.R. Menck The national cancer data base report on pancreatic cancer Cancer 76 1995 1671
66. S.S. Nitecki M.G. Sarr T.V. Colby Long-term survival after resection for ductal adenocarcinoma of the pancreas Ann Surg 221 1995 59
67. D. Oda C.E. Savard T.D. Nguyen Culture of human main pancreatic duct epithelial cells In Vitro Cell Dev Biol Anim 34 1998 211
68. T. Okai H. Watanabe Y. Yamaguchi EUS and K-ras analysis of pure pancreatic juice collected via a duodenoscope after secretin stimulation for diagnosis of pancreatic mass lesion: a prospective study Gastrointest Endosc 50 1999 797
69. H. Ozcelik B. Schmocker N. DiNicola Germline BRCA2 617delT mutations in Ashkenazi Jewish pancreatic cancer patients Nat Genet 16 1997 17
70. A.A. Parikh A.M. Lowy Pancreatic cancer: can we screen? How should we stage? Curr Gastroenterol Rep 1 1999 166
71. A.S. Rigg N.R. Lemoine Genetic prodrug activation therapy for pancreatic cancer Ann N Y Acad Sci 880 1999 319
72. E. Rozenblum M. Schutte M. Goggins Tumor-suppressive pathways in pancreatic carcinoma Cancer Res 57 1997 1731
73. B.A. Ruggeri L. Huang D. Berger Molecular pathology of primary and metastatic ductal lesions: Analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions Cancer 79 1997 700
74. M. Schutte R.H. Hruban J. Geradts Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas Cancer Res 57 1997 3126
75. A.B. Seymour R.H. Hruban M. Redston Allelotype of pancreatic adenocarcinoma Cancer Res 54 1994 2761
76. Q. Shi J.L. Abbruzzese S. Huang Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic Clin Cancer Res 5 1999 3711
77. V. Sirivatanauksorn Y. Sirivatanauksorn N.R. Lemoine Molecular pattern of ductal pancreatic cancer Langenbecks Arch Surg 383 1998 105
78. J.P. Smith A. Shih Y. Wu Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion Am J Physiol 270 1996 R1078
79. G.H. Su W. Hilgers D. Shekher Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene Cancer Res 58 1998 2339
80. G.H. Su R.H. Hruban G.S. Bova Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers Am J Pathol 154 1999 1835
81. T. Taniguchi A.K. Kakkar E.G. Tuddenham Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer Cancer Res 58 1998 4461
82. S.T. Tinsley H.T. Lynch Integration of family history and medical management of patients with hereditary cancers Cancer 86 suppl 11 1999 2525
83. C.D. Ulrich M. Holtmann L.J. Miller Secretin and vasoactive intestinal peptide receptors: Members of a unique family of G protein-coupled receptors Gastroenterology 114 1998 382
84. Van Hinsbergh V.W. A. Collen P. Koolwijk Angiogenesis and anti-angiogenesis: Perspectives for the treatment of solid tumors Ann Oncol 10 suppl 4 1999 60
85. Von Meyenfeldt M.F. Nutritional support during treatment of biliopancreatic malignancy Ann Oncol 10 suppl 4 1999 273
86. M. Wagner T. Cao M.E. Lopez Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum Int J Cancer 68 1996 782
87. C. Wallrapp F. Muller-Pillasch S. Solinas-Toldo Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene Cancer Res 57 1997 3135
88. F. Wang J. Larsson T.E. Adrian In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets J Surg Res 79 1998 13
89. Warshaw A.L. Fernandez-Del Castillo C. Pancreatic carcinoma N Engl J Med 326 1992 455
90. D.C. Whitcomb S. Applebaum S.P. Martin Hereditary pancreatitis and pancreatic carcinoma Ann N Y Acad Sci 880 1999 201
91. D.C. Whitcomb C.D. Ulrich Hereditary pancreatitis: New insights new directions Baillieres Clin Gastroenterol 13 1999 253
92. X.C. Xu U. Strier S. Rosewicz Differential suppression of nuclear retinoic acid receptor β in pancreatic carcinomas Int J Oncol 8 1996 445
93. C.J. Yeo R.A. Abrams L.B. Grochow Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival: A prospective, single institution experience Ann Surg 225 1997 621
94. I.S. Zagon J.P. Smith P.J. McLaughlin Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor Int J Oncol 14 1999 577
95. Z. Zhu H. Friess diMola F.F. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer J Clin Oncol 17 1999 2419